Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Melanoma and FAS[original query] |
---|
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenetics and genomics 2006 Apr 16 (4): 253-63. Li Chunying, Larson Derek, Zhang Zhengdong, Liu Zhensheng, Strom Sara S, Gershenwald Jeffrey E, Prieto Victor G, Lee Jeffrey E, Ross Merrick I, Mansfield Paul F, Cormier Janice N, Duvic Madeleine, Grimm Elizabeth A, Wei Qing |
Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis. Cancer journal (Sudbury, Mass.) 0 13 (4): 233-7. Zhang Hong, Sun Xiao-Feng, Synnerstad Ingrid, Rosdahl Ing |
FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies. Carcinogenesis 2009 Mar 30 (3): 487-93. Zhang Zhizhong, Xue Hengchuan, Gong Weida, Wang Meilin, Yuan Lin, Han Suping, Zhang Zhengdo |
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma. EBioMedicine 2018 May . Xiao Wenjing, Du Nan, Huang Taoyuan, Guo Jinan, Mo Xingkui, Yuan Tao, Chen Yong, Ye Ting, Xu Chunwei, Wang Wenxian, Wang Guoqiang, Cai Shangli, Chen Ji |
- Page last reviewed:Feb 1, 2024
- Content source: